logoTry Persana

Sutro Biopharma, Inc. - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Sutro Biopharma, Inc. including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Sutro Biopharma, Inc. company logo

Changing the future of Oncology

Sutro Biopharma, Inc. is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients.

HeadquartersSouth San Francisco, United States
Team size201-500
Founded2003

What is Sutro Biopharma, Inc.? - Company Overview & Details

Sutro Biopharma, Inc. is Sutro Biopharma, Inc. is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients. Founded in 2003, the company is headquartered in South San Francisco, United States.

Who Founded Sutro Biopharma, Inc.?

Sutro Biopharma, Inc. was founded by James R. Swartz, Sutanto Widjaja.

Who are the Key Executives at Sutro Biopharma, Inc.? - Leadership Team

Sutro Biopharma, Inc. is led by experienced executives in key positions:

Sutro Biopharma, Inc. Company Details & Key Information

Where is Sutro Biopharma, Inc. located?

Sutro Biopharma, Inc. is headquartered in South San Francisco, United States.

How many employees does Sutro Biopharma, Inc. have?

Sutro Biopharma, Inc. has 201-500 employees.

When was Sutro Biopharma, Inc. founded?

Sutro Biopharma, Inc. was founded in 2003.

How much funding has Sutro Biopharma, Inc. raised?

Sutro Biopharma, Inc. has raised $75 Million across 12 funding rounds. The most recent funding was completed on 2023-06-02.

Funding Overview

Sutro Biopharma, Inc. has raised a total of $75 million from its latest funding round.

$75 Million
Total Funding Raised
12
Funding Rounds
2023-06-02
Latest Round

Sutro Biopharma, Inc. Funding History

Post IPO equity
2024-05-02
$75 Million

Who are the key investors in Sutro Biopharma, Inc.?

Sutro Biopharma, Inc. is backed by 2 key investors including Samsara BioCapital, Surveyor Capital. These investors focus on Biotechnology, Healthcare, Investments sectors.

Sutro Biopharma, Inc. Investor Overview

2
Key Investors
4
Focus Areas
2
Notable Investments

Complete List of Sutro Biopharma, Inc. Investors

Samsara BioCapital

Samsara is a private equity firm that invests in biotechnology companies.

Investment Focus
Biotechnology
Healthcare
Notable Portfolio Companies
Sutro Biopharma

Surveyor Capital

Surveyor is part of Citadel LLC, focusing on forward-looking investments in various sectors.

Investment Focus
Investments
Equity
Notable Portfolio Companies
Sutro Biopharma

What sectors do Sutro Biopharma, Inc. investors focus on?

The investors backing Sutro Biopharma, Inc. primarily focus on Biotechnology, Healthcare, Investments, Equity sectors.

Biotechnology
Healthcare
Investments
Equity

Featured Investor: Samsara BioCapital

Samsara BioCapital

Samsara is a private equity firm that invests in biotechnology companies.

Notable Investments: Sutro Biopharma

What are Sutro Biopharma, Inc.'s future plans?

Sutro Biopharma, Inc. Continue advancing clinical trials for cancer therapies and enhancing regulatory collaborations.

Sutro Biopharma, Inc. Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Sutro Biopharma, Inc. face?

Sutro Biopharma, Inc. has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Sutro Biopharma, Inc.

1

Competition in the biotechnology sector

2

Regulatory hurdles

What opportunities does Sutro Biopharma, Inc. have?

Sutro Biopharma, Inc. has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Sutro Biopharma, Inc.

1

Expanding product pipeline

2

Collaborations with other pharmaceutical companies

Sutro Biopharma, Inc. Strategic Position Summary

Key Focus Areas

Sutro Biopharma, Inc. is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Sutro Biopharma, Inc.?

Sutro Biopharma, Inc. has 2 recent news updates covering key business developments and market activities.

Sutro Biopharma, Inc. News Overview

2
Recent Articles
Active
Media Coverage
2025-07-22
Latest Update

What is Sutro Biopharma, Inc. in the news for?

Sutro Biopharma, Inc. is currently featured in news for Sutro Biopharma, Inc partnered with U.S. Food and Drug Administration on Jul 22nd '25. and other significant business developments.

Recent News Articles About Sutro Biopharma, Inc.

Article 1
2025-07-22

Sutro Biopharma, Inc partnered with U.S. Food and Drug Administration on Jul 22nd '25.

Sutro Biopharma announces research collaboration with the FDA to develop reference materials to improve regulatory standards for ADC drug development.

sutrobio.com
Read News
Article 2
2025-06-02

Sutro Biopharma, Inc hired Greg Chow as Chief Financial Officer on Jun 2nd '25.

Sutro Biopharma appoints Greg Chow as Chief Financial Officer.

sutrobio.com
Read News

Sutro Biopharma, Inc. FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Sutro Biopharma, Inc. including information about founders, CEO, funding history, investors, headquarters location, and company details. 15 frequently asked questions covering key information about the company.

Sutro Biopharma, Inc. Questions & Answers - Company Information

Q1

What is Sutro Biopharma, Inc.?

Sutro Biopharma, Inc. is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients.

Q2

Who founded Sutro Biopharma, Inc.?

Sutro Biopharma, Inc. was founded by James R. Swartz, Sutanto Widjaja.

Q3

How much funding has Sutro Biopharma, Inc. raised?

Sutro Biopharma, Inc. has raised a total of $$75 Million across 12 funding rounds. The most recent funding was completed on 2023-06-02.

Q4

Who are the investors in Sutro Biopharma, Inc.?

Sutro Biopharma, Inc.'s key investors include Samsara BioCapital, Surveyor Capital.

Q5

Where is Sutro Biopharma, Inc. headquartered?

Sutro Biopharma, Inc. is headquartered in South San Francisco, United States.

Q6

When was Sutro Biopharma, Inc. founded?

Sutro Biopharma, Inc. was founded in 2003.

Q7

How many employees does Sutro Biopharma, Inc. have?

Sutro Biopharma, Inc. has 201-500 employees.

Q8

What was Sutro Biopharma, Inc.'s latest funding round?

Sutro Biopharma, Inc.'s latest funding round was a Post IPO equity round of $$75 Million completed on 2024-05-02.

Q9

What does the company do?

Sutro Biopharma, Inc. is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients.

Q10

How much funding?

$75 Million

Q11

Latest funding date?

2024-05-02

Q12

Who are the investors?

Samsara BioCapital Surveyor Capital

Q13

What are the challenges?

Competition in the biotechnology sector Regulatory hurdles

Q14

What are the opportunities?

Expanding product pipeline Collaborations with other pharmaceutical companies

Q15

Latest news?

Sutro Biopharma announces research collaboration with the FDA to develop reference materials to improve regulatory standards for ADC drug development. Sutro Biopharma appoints Greg Chow as Chief Financial Officer.

More Information About Sutro Biopharma, Inc.

For additional details about Sutro Biopharma, Inc., including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.